Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease

References

• CriquiMHPeripheral arterial disease – epidemiological aspectsVasc Med200163 Suppl3711789963
   PubMed Web of Science ®Google Scholar
• SawJBhattDLMoliternoDJThe influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trialsJ Am Coll Cardiol20064881567157217045889
   PubMed Web of Science ®Google Scholar
• CriquiMHLangerRDFronekAMortality over a period of 10 years in patients with peripheral arterial diseaseN Engl J Med199232663813861729621
   PubMed Web of Science ®Google Scholar
• CriquiMHNinomiyaJKWingardDLJiMFronekAProgression of peripheral arterial disease predicts cardiovascular disease morbidity and mortalityJ Am Coll Cardiol200852211736174219007695
   PubMed Web of Science ®Google Scholar
• FowkesFGPriceJFStewartMCAspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trialJAMA2010303984184820197530
   PubMed Web of Science ®Google Scholar
• McDermottMMMehtaSAhnHGreenlandPAtherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery diseaseJ Gen Intern Med19971242092159127224
   PubMed Web of Science ®Google Scholar
• WeltenGMSchoutenOHoeksSELong-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery diseaseJ Am Coll Cardiol200851161588159618420103
   PubMed Web of Science ®Google Scholar
• MahoneyEMWangKKeoHHVascular hospitalization rates and costs in patients with peripheral artery disease in the United StatesCirc Cardiovasc Qual Outcomes20103664265120940249
   PubMed Web of Science ®Google Scholar
• HirschATHaskalZJHertzerNRACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease FoundationCirculation200611311e463e65416549646
   PubMed Web of Science ®Google Scholar
• OlinJWAllieDEBelkinMACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease)Circulation2010122242583261821126978
   PubMed Web of Science ®Google Scholar
• SmithSCJrBenjaminEJBonowROAHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses AssociationJ Am Coll Cardiol201158232432244622055990
   PubMed Web of Science ®Google Scholar
• HirschATCriquiMHTreat-JacobsonDPeripheral arterial disease detection, awareness, and treatment in primary careJAMA2001286111317132411560536
   PubMed Web of Science ®Google Scholar
• ArdatiAKKaufmanSRAronowHDThe quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventionsCirc Cardiovasc Interv20125685085523233746
   PubMed Web of Science ®Google Scholar
• PandeRLPerlsteinTSBeckmanJACreagerMASecondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004Circulation20111241172321690489
   PubMed Web of Science ®Google Scholar
• SubherwalSPatelMRKoberLMissed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remainsCirculation2012126111345135422874581
   PubMed Web of Science ®Google Scholar
• McCoachCEArmstrongEJSinghSGender-related variation in the clinical presentation and outcomes of critical limb ischemiaVasc Med2013181192623439776
   PubMed Web of Science ®Google Scholar
• SmithSCJrAllenJBlairSNAHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood InstituteCirculation2006113192363237216702489
   PubMed Web of Science ®Google Scholar
• StegPGBhattDLWilsonPWOne-year cardiovascular event rates in outpatients with atherothrombosisJAMA2007297111197120617374814
   PubMed Web of Science ®Google Scholar
• HoeksSEScholte op ReimerWJvan GestelYRMedication underuse during long-term follow-up in patients with peripheral arterial diseaseCirc Cardiovasc Qual Outcomes20092433834320031859
   PubMed Web of Science ®Google Scholar
• MukherjeeDLingamPChetcutiSMissed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)Circulation2002106151909191212370211
   PubMed Web of Science ®Google Scholar
• CacoubPPAbolaMTBaumgartnerICardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) RegistryAtherosclerosis20092042e86e9219054514
   PubMedGoogle Scholar
• McDermottMMGuralnikJMGreenlandPStatin use and leg functioning in patients with and without lower-extremity peripheral arterial diseaseCirculation2003107575776112578881
   PubMed Web of Science ®Google Scholar
• GiriJMcDermottMMGreenlandPStatin use and functional decline in patients with and without peripheral arterial diseaseJ Am Coll Cardiol2006475998100416516084
   PubMed Web of Science ®Google Scholar
• MohlerER3rdHiattWRCreagerMACholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial diseaseCirculation2003108121481148612952839
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative GroupMRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trialLancet2002360932672212114036
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative GroupStatin cost-effectiveness in the United States for people at different vascular risk levelsCirc Cardiovasc Qual Outcomes200922657220031817
   PubMed Web of Science ®Google Scholar
• FeringaHHKaragiannisSEvan WaningVHThe effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial diseaseJ Vasc Surg200745593694317360142
   PubMed Web of Science ®Google Scholar
• MorenoPRFusterVThe year in atherothrombosisJ Am Coll Cardiol200444112099211015582305
   PubMed Web of Science ®Google Scholar
• WestinGGArmstrongEJBangHAssociation between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemiaJ Am Coll Cardiol201463768269024315911
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation201412925 Suppl 2S1S4524222016
   PubMed Web of Science ®Google Scholar
• YusufSSleightPPogueJBoschJDaviesRDagenaisGEffects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study InvestigatorsN Engl J Med2000342314515310639539
   PubMed Web of Science ®Google Scholar
• FeringaHHvan WaningVHBaxJJCardioprotective medication is associated with improved survival in patients with peripheral arterial diseaseJ Am Coll Cardiol20064761182118716545650
   PubMed Web of Science ®Google Scholar
• AhimastosAAWalkerPJAskewCEffect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trialJAMA2013309545346023385271
   PubMed Web of Science ®Google Scholar
• ArmstrongEJChenDCWestinGGAdherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial diseaseJ Am Heart Assoc201432e00069724721799
   PubMed Web of Science ®Google Scholar
• MehtaRHMontoyeCKGalloglyMImproving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) InitiativeJAMA2002287101269127611886318
   PubMed Web of Science ®Google Scholar
• LewisWRPetersonEDCannonCPAn organized approach to improvement in guideline adherence for acute myocardial infarction: results with the Get With The Guidelines quality improvement programArch Intern Med2008168161813181918779470
   PubMedGoogle Scholar
• BufalinoVBaumanMAShubrookJHEvolution of “the guideline advantage”: lessons learned from the front lines of outpatient performance measurementCirc Cardiovasc Qual Outcomes20147349349824785960
   PubMed Web of Science ®Google Scholar
• SchwammLHFonarowGCReevesMJGet With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attackCirculation2009119110711519075103
   PubMed Web of Science ®Google Scholar